Potent, orally bioavailable somatostatin agonists: good absorption achieved by urea backbone cyclization.

[1]  A. Patchett,et al.  Spiro[1H-indene-1,4'-piperidine] derivatives as potent and selective non-peptide human somatostatin receptor subtype 2 (sst2) agonists. , 1998, Journal of medicinal chemistry.

[2]  C. Stidsen,et al.  Discovery of a Novel Non-Peptide Somatostatin Agonist with SST4 Selectivity , 1998 .

[3]  G. Liapakis,et al.  Identification of Ligand Binding Determinants in the Somatostatin Receptor Subtypes 1 and 2* , 1996, The Journal of Biological Chemistry.

[4]  G. Liapakis,et al.  Development of a selective agonist at the somatostatin receptor subtype sstr1. , 1996, The Journal of pharmacology and experimental therapeutics.

[5]  E. Ravussin,et al.  Metabolic differences and the development of obesity. , 1995, Metabolism: clinical and experimental.

[6]  C. B. Srikant,et al.  Subtype selectivity of peptide analogs for all five cloned human somatostatin receptors (hsstr 1-5). , 1994, Endocrinology.

[7]  P. Darke,et al.  Design and synthesis of peptidomimetic inhibitors of HIV-1 protease and renin. Evidence for improved transport. , 1994, Journal of medicinal chemistry.

[8]  Joseph M. Salvino,et al.  De novo design and synthesis of somatostatin non-peptide peptidomimetics utilizing beta-D-glucose as a novel scaffolding , 1993 .

[9]  T. Reisine,et al.  Main chain and side chain chiral methylated somatostatin analogs : syntheses and conformational analyses , 1992 .

[10]  C. Saper,et al.  Cloning of a novel somatostatin receptor, SSTR3, coupled to adenylylcyclase. , 1992, The Journal of biological chemistry.

[11]  J. Vida,et al.  Conformationally directed drug design : peptides and nucleic acids as templates or targets : based on a symposium sponsored by the Division of Medicinal Chemistry at the 186th Meeting of the American Chemical Society, Washington, D.C., August 28-September 2, 1983 , 1984 .

[12]  C. J. Goodner,et al.  Effects of somatostatin on hemostasis in baboons. , 1975, The New England journal of medicine.

[13]  G. Grodsky,et al.  Inhibition by somatostatin of glucagon and insulin release from the perfused rat pancreas in response to arginine, isoproterenol and theophylline: evidence for a preferential effect on glucagon secretion. , 1975, Endocrinology.

[14]  N. Ling,et al.  Hypothalamic Polypeptide That Inhibits the Secretion of Immunoreactive Pituitary Growth Hormone , 1973, Science.

[15]  S. Efendić,et al.  Effects of somatostatin on gastrointestinal propagation and absorption of oral glucose in man. , 1981, Digestion.